|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - Hearne Michael S
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-03-07 Purchase |
2019-03-11 5:42 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO, 10% Owner |
140,000 | $18.26 | $2,556,316 | 13,086,038 (Indirect) |
View |
| 2018-12-27 Purchase |
2018-12-31 5:17 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO, 10% Owner |
63,700 | $13.11 | $835,107 | 12,946,038 (Indirect) |
View |
| 2018-12-20 Purchase |
2018-12-26 6:21 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO, 10% Owner |
60,000 | $12.6 | $755,857 | 12,882,338 (Indirect) |
View |
| 2018-12-14 Purchase |
2018-12-18 5:58 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO, 10% Owner |
40,000 | $14.67 | $586,639 | 12,822,338 (Indirect) |
View |
| 2018-12-11 Purchase |
2018-12-13 8:18 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO, 10% Owner |
20,000 | $15.6 | $312,073 | 12,782,338 (Indirect) |
View |
| 2018-12-06 Purchase |
2018-12-10 6:24 pm |
Odonate Therapeutics Inc. | ODT | TANG KEVIN C TANG CAPITAL PARTNERS LP TANG CAPITAL MANAGEMENT LLC Lemkey John G Hearne Michael S CEO, 10% Owner |
20,000 | $14.79 | $295,864 | 12,762,338 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-05-15 Option Award |
2019-05-17 6:05 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
29 | $18.87 | 13,086,038 (Direct) |
View |
| 2019-05-15 Option Award |
2019-05-17 6:05 pm |
N/A 2029-05-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
29 | $22.2 | 13,086,038 (Direct) |
View |
| 2019-04-30 Option Award |
2019-05-02 7:58 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
33 | $16.71 | 13,086,038 (Direct) |
View |
| 2019-04-30 Option Award |
2019-05-02 7:58 pm |
N/A 2029-04-30 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
33 | $19.66 | 13,086,038 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
26 | $21.24 | 13,086,038 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 4:04 pm |
N/A 2029-04-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
26 | $24.99 | 13,086,038 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 4:39 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
29 | $18.79 | 13,086,038 (Direct) |
View |
| 2019-03-29 Option Award |
2019-04-02 4:39 pm |
N/A 2029-03-29 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
29 | $22.11 | 13,086,038 (Direct) |
View |
| 2019-03-15 Option Award |
2019-03-19 4:04 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
27 | $20.19 | 13,086,038 (Direct) |
View |
| 2019-03-15 Option Award |
2019-03-19 4:04 pm |
N/A 2029-03-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
27 | $23.75 | 13,086,038 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 4:48 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
39 | $14.01 | 12,946,038 (Direct) |
View |
| 2019-02-28 Option Award |
2019-03-04 4:48 pm |
N/A 2029-02-28 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
39 | $16.48 | 12,946,038 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-20 5:30 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
39 | $14.04 | 12,946,038 (Direct) |
View |
| 2019-02-15 Option Award |
2019-02-20 5:30 pm |
N/A 2029-02-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
39 | $16.52 | 12,946,038 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 9:31 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
38 | $14.08 | 12,946,038 (Direct) |
View |
| 2019-01-31 Option Award |
2019-02-04 9:31 pm |
N/A 2029-01-31 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
38 | $16.57 | 12,946,038 (Direct) |
View |
| 2019-01-15 Option Award |
2019-01-17 7:15 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
40 | $13.85 | 12,946,038 (Direct) |
View |
| 2019-01-15 Option Award |
2019-01-17 7:15 pm |
N/A 2029-01-15 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
40 | $16.29 | 12,946,038 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 8:10 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
45 | $11.97 | 12,946,038 (Direct) |
View |
| 2018-12-31 Option Award |
2019-01-03 8:10 pm |
N/A 2028-12-31 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
45,045 | $14.08 | 12,946,038 (Direct) |
View |
| 2018-12-14 Option Award |
2018-12-18 6:00 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
42 | $12.85 | 12,822,338 (Direct) |
View |
| 2018-12-14 Option Award |
2018-12-18 6:00 pm |
N/A 2028-12-14 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
42 | $15.12 | 12,822,338 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-04 6:27 pm |
N/A N/A |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
40 | $13.4 | 12,742,338 (Direct) |
View |
| 2018-11-30 Option Award |
2018-12-04 6:27 pm |
N/A 2028-11-30 |
Odonate Therapeutics Inc. | ODT | Hearne Michael S CFO |
40 | $15.76 | 12,742,338 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Sun, 19 May 2019 22:15:19 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |